Cryptococcus neoformans is an encapsulated fungal pathogen that causes infection in
immunocompromised individuals such as HIV patients, organ transplant patients …

Antibody-based therapies are currently undergoing a renaissance. After being developed
and then largely abandoned in the twentieth century, many antibody preparations are now in …

The capsule of the fungal pathogen Cryptococcus neoformans has been studied extensively
in recent decades and a large body of information is now available to the scientific …

Recent studies show an important role for non-neutralizing anti-spike antibodies, including
monoclonal antibodies (mAbs), in robustly protecting against SARS-CoV-2 infection. These …

Spike-specific antibodies are central to effective COVID19 immunity. Research efforts have
focused on antibodies that neutralize the ACE2-Spike interaction but not on non-neutralizing …

Antibody therapies such as convalescent plasma and monoclonal antibodies have emerged
as major potential therapeutics for coronavirus disease 2019 (COVID-19). Immunoglobulins …

Nations' ongoing struggles with a number of novel and reemerging infectious diseases,
including the ongoing global health issue, the SARS-Co-V2 (severe acute respiratory …

Much has been learned about the structure, function, and production of IgM, since the
antibody's initial characterization. It is widely accepted that IgM provides a first line of …

Opportunistic pathogens have become of increasing medical importance over the last
decade due to the AIDS pandemic. Not only is cryptococcosis the fourth-most-common fatal …

Host immunity is essential in facilitating the eradication of infection. However, immunological
recovery and an imbalance characterised by either suboptimum or excessive expression of …